Skip to content
All Updates
- Decisions of 68th Meeting of Medical Device Board (Deficiency letter for Medical Devices Applications)June 13, 2024
- Series of Training on National Pharmacovigilance System for Registration holders (Manufacturers and Importers)June 12, 2024
- Rapid Alert: Busting of Illegal Manufacturing Site producing Unregistered Boostin (RBST) InjectionsJune 10, 2024
- Recall Alert: Drug Product; Water for Injection (Batch 989) by Zafa Pharmaceutical Pvt Ltd, KarachiJune 10, 2024
- Tender notice for supply of Fourier Transform Infrared Spectrophotometer (FTIR) to CDL Karachi)May 31, 2024
- Voluntary Recall Alert: Drug Product; Cadlec 30mg/mL Injection by Brooks Pharma Pvt Ltd., KarachiMay 29, 2024
- Introducing Centralized Case Management System for Enhanced Efficiency and TransparencyMay 29, 2024
- Rapid Alert: Drug Product; Falsified Froxime 100mg/5mL Powder for Oral SuspensionMay 28, 2024
- Recall Alert: Drug Product; Zaftolin 5mg/ml Solution by Zafa Pharmaceutical Pvt Ltd, KarachiMay 21, 2024
- Minutes of 335th meeting of Registration Board held on 25th April, 2024May 20, 2024
- Rapid Alert: Contaminated Lot of Sorbitol Identified in KarachiMay 17, 2024
- Recall Alert: Drug Product; Novarise 50mg/5ml Syrup by Sharooq Pharmaceuticals, LahoreMay 16, 2024
- Report on Availability Status and Supply Disruption of Eye DropsMay 13, 2024
- Drug Safety Alert: Risk of Medication Errors resulting Errors resulting due to inadvertent intrathecal Tranexmic Acid InjectionMay 10, 2024
- Drug Safety Alert: Risks associated with the use of Valproic Acid in Women and Girls of Childbearing potential and minor potential risk in male patients.May 10, 2024
- Minutes of 297th Meeting of Central Licensing Board held on 2nd May, 2024May 9, 2024
- Visiting hours of DRAPMay 9, 2024
- Expressions of Interest (EOI) for pool of expert members of central licensing board of DRAPMay 9, 2024
- Drug Safety Alert: Risk of Posterior Reversible Encephalopathy Syndrome (PRES) and Reversible Cerebral Vasoconstriction Syndrome (RCVS) with Pseudoephedrine Containing Medicines.May 7, 2024
- Drug Safety Alert: Risk of Haemophagocytic Lymphohistiocytosis (HLH) with Sulfamethoxazole and Trimethoprim combination.May 7, 2024
- Drug Safety Alert: Risk of Myasthenia Gravis and Ocular Myasthenia with Statins.May 7, 2024
- Schedule of Meetings of Clinical Studies Committee (CSC) for the Year 2024April 30, 2024
- Change in Manufacturing Unit of M/s Sois Life Sciences to Site at G-77. S.I.T.E. Super Highway, Phase-II, Karachi.April 30, 2024
- Minutes of 48th Meeting of Clinical Studies CommitteeApril 30, 2024
- Minutes of 296th Meeting of Central Licensing Board held on 2nd April, 2024April 29, 2024
- Recall Alert; Drug Products: Mebzole 100mg/5mL Suspension and Bioris 1mg/ml Oral Solution by M/s Biolabs Pvt., Ltd., IslamabadApril 29, 2024
- Recall Alert; 03 Batches of Veterinary Drug Products by M/s Biolabs Pvt., Ltd., IslamabadApril 28, 2024
- Recall Alert; Drug Products: Artecid 75mg/3mL Injections by M/s Biolabs Pvt., Ltd., IslamabadApril 28, 2024
- Decisions of 67th Meeting of Medical Device Board (Deficiency letter for Medical Devices Applications)April 26, 2024
- Decisions of 66th Meeting of Medical Device Board (Deficiency letter for Medical Devices Applications)April 26, 2024
- Drug Safety Alert: Risk of Neurodevelopmental Disorders in Children during Pregnancy with TopirmateApril 25, 2024
- Implementation of Post Registration Variation Guidelines for Pharmaceutical and Biological Products (2nd Edition)April 24, 2024
- Drug Safety Alert: Risk of Rare and Serious Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) with Levetiracetam and ClobazamApril 24, 2024
- Drug Safety Alert: Risk of Ocular Adverse Events with MiltefosineApril 24, 2024
- Stakeholder Nominations are invited to a Webinar on GMP for Blood EstablishmentApril 21, 2024
- Decisions of 65th Meeting of Medical Device Board (Deficiency letter for Medical Devices Applications)April 8, 2024
- Combating Substandard and Falsified Products : Public Alert ReportingApril 4, 2024
- Minutes of 4th Meeting of the Pharmacovigilance Risk Assessment Expert Committee (PRAEC) held on Feburary 26, 2024March 27, 2024
- Rapid Alert: Drug Product; Falsified Risek 40mg Injection identified in the MarketMarch 27, 2024
- DRAP Releases 2nd Edition of Guidelines for Good Clinical Practice (GCP) InspectionsMarch 18, 2024
- Recall Alert: Drug Product; Barpon 100mg/5mL Suspension (Batch # 202) by M/s. JASM Pharmaceutical, KPKMarch 14, 2024
- Rapid Alert: Contaminated Propylene Glycol Identified and ConfiscatedMarch 11, 2024
- Rapid Alert: Substandard Propylene Glycol (Batch # G01821UG) claimed to be manufactured by SK Picoglobal Korea.March 8, 2024
- Switching Over to Pakistan Single Window (PSW) for Drug Import License and Import Release of Donations MedicinesMarch 7, 2024
- Rapid Alert: Contaminated Propylene Glycol Identified and ConfiscatedMarch 7, 2024
- Guidelines on Risk Based Sampling and Testing of Drugs; Comments invited on draft DocumentMarch 1, 2024
- Minutes of 295th Meeting of Central Licensing Board held on 11th January 2024March 1, 2024
- Recall Alert: Drug Product; DXL 60mg Capsule (Batch # 23136) by M/s. Titlis Pharma LahoreFebruary 28, 2024
- Recall Alert: Drug Product; Mencobal 500mcg Injection (Batch # 082) by M/s. Treat Pharmaceutical Industry (Pvt.) Ltd.,Bannu.February 28, 2024
- Recall Alert: Drug Product; SN ZOR 200mg/5mL Suspension (Batch # 342) by M/s. S.N.B Pharma (Pvt) Ltd. PeshwarFebruary 27, 2024
